原发性乳腺恶性淋巴瘤诊断及治疗进展  

Advances in diagnosis and treatment of malignant primary breast lymphoma

作　　者：侯训博 秦优优[1] 徐宇航[1] 杨学伟[1] 

机构地区：[1]哈尔滨医科大学附属第二医院乳腺外科

出　　处：《临床外科杂志》2015年第12期952-954,共3页Journal of Clinical Surgery

摘　　要：原发性乳腺恶性淋巴瘤发病率极低，占乳腺恶性肿瘤的比例不足0．5％，其临床表现缺乏特异性，常以单侧乳房无痛性乳腺肿块为首发症状；病理组织学检查是该疾病诊断与鉴别诊断重点，病理类型以弥漫大B细胞淋巴瘤居多，治疗方式不同于乳腺癌，宜以化疗为主，并辅以放疗等的综合治疗；易发生全身扩散以及中枢性复发，预后较差。Malignant primary breast lymphoma（PBL）has an extremely low morbidity, accounting for less than 0.5% of mammary gland malignant tumors. Lacking of specific clinical manifestations ,its primary symptom is usually unilateral painless breast lump. Histologic diagnosis is the key point to its diagnosis and antidiastole and diffuse large B cell lymphoma is the major pathological type, whose therapeutic strategy is different from the breast cancer. Comprehensive therapy relies mainly on chemotherapy supplemented by radiotherapy. Poor prognosis is due to its tendency to systemic metastases and recurrence in the central nervous system.

关 键 词：原发性乳腺恶性淋巴瘤 治疗 预后 

分 类 号：R737.9[医药卫生—肿瘤]